Skip to main content
. 2021 May 10;13(9):2284. doi: 10.3390/cancers13092284

Table 1.

Analysis of the drug interaction between PLX4032 and orlistat in LM16 R cells 1.

Variable CI ²
PLX4032 3 µM orlistat 10 µM orlistat
30 µM 0.22 ± 0.16 0.39 ± 0.11
10 µM 0.68 ± 0.07 1.11 ± 0.35
3 µM 1.39 ± 0.3 1.40 ± 0.53
1 µM 4.3 ± 3.24 1.79 ± 0.62

1, Cell sensitivity was assessed by cell growth inhibition assay. Cells were seeded and 24 h later exposed to each drug and to their simultaneous combination for 72 h. Cells were then counted using a cell counter. 2, The drug interaction was analyzed by the Chou and Talalay method, calculating a combination index (CI). CI values indicating synergistic drug interactions are in bold. Mean CI values ± SE of three independent experiments are reported.